Global Infusion Therapy Devices Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Infusion Therapy Devices Industry In 2025?

The market for infusion therapy apparatus has experienced swift expansion lately, projected to escalate from a valuation of $12.1 billion in 2024 to $13.33 billion by the subsequent year, reflecting a compounded annual growth trajectory of 10.2%; this upswing during the past timeframe is fundamentally linked to a rise in patient admissions to healthcare facilities, advancements in medical groundwork, supportive governmental programs, the expansion of medical travel, and supportive mechanisms for reimbursement.

Projections indicate that the market for infusion therapy devices is poised for swift expansion in the years ahead, reaching a valuation of $19.82 billion by 2029, driven by a compound annual growth rate (CAGR) of 10.4%.This upward trajectory throughout the projected timeframe is largely fueled by developments in personalized medical treatments, ongoing efforts in pandemic readiness and reaction, the emergence of wearable infusion apparatuses, a noticeable movement favoring infusion-based care, and broader healthcare digitization initiatives.Key developments anticipated to shape this period involve the adoption of 5G network capabilities, the advent of quantum computing, the integration of the Internet of Things (IoT), advancements in wearable health technology, and the utilization of voice assistants alongside natural language processing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

Which Major Market Drivers Are Shaping The Future Of The Infusion Therapy Devices Market?

The escalating incidence of conditions categorized as long-term ailments—health issues persisting over a year that necessitate continuous medical management or restrict everyday functioning—is anticipated to fuel the expansion of the infusion therapy devices sector moving ahead. This heightened frequency of persistent diseases stems from diverse elements, including suboptimal lifestyle decisions, inactivity, poor eating patterns, and environmental factors, compounded by the proliferation of risk elements like obesity, tobacco use, and elevated stress levels. Infusion therapy apparatus plays a critical role in managing these protracted conditions through the accurate, regulated administration of therapeutic agents and fluids right into the circulatory system, thereby guaranteeing uniform and efficacious care for ailments such as diabetes, immune system dysfunctions, and malignancies, which ultimately leads to superior patient results, increased ease of use, and fewer mandatory hospital admissions. Illustratively, data from the US National Center for Biotechnology Information (NCBI) indicated in January 2023 an expectation that the population aged 50 and older suffering from a minimum of one chronic ailment will almost double by 2050, jumping from 71.522 million in 2020 to an estimated 142.66 million; consequently, the burgeoning rate of chronic illnesses stands as a key impetus for the market growth of infusion therapy equipment.

What Are The Major Segment Types Covered In The Infusion Therapy Devices Market?

The infusion therapy devicesmarket covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

How Are Emerging Market Trends Shaping The Infusion Therapy Devices Industry Landscape?

Key players within the infusion therapy devices sector are prioritizing the creation of novel approaches, such as pressure-enabled drug delivery (PEDD) technology, aimed at augmenting the therapeutic management of malignancies affecting the liver and pancreas. PEDD denotes a method of administering therapeutic agents where mechanical pressure facilitates their introduction into target tissues or organs, especially overcoming obstacles encountered with standard infusion techniques. As an illustration, in the month of November in 2024, TriSalus Life Sciences, a medical technology firm situated in the United States, introduced both the TriNav LV Infusion System and the TriGuide Guiding Catheters, thereby broadening their suite utilizing PEDD technology to refine the infusion of treatments, thus improving therapeutic choices and possibly yielding better results for individuals requiring care. The TriNav LV Infusion System boasts distinct attributes, including suitability for larger blood vessels ranging from 3.5 to 5.0 mm, which broadens the applicability of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) method across a larger cohort of patients, extending its device compatibility for PEDD from vessels measuring 1.5 mm up to 5.0 mm and furnishing interventional radiologists with increased procedural selections. Furthermore, the TriGuide Guiding Catheters are equipped with a wider internal bore, a low-friction internal coating, and an inverted curve architecture engineered to simplify access via the femoral artery and boost the efficiency of procedures; initial feedback from practitioners indicates a satisfaction level of 97 percent, underscoring the apparatus’s efficacy and user-friendliness in cancer therapy applications.

Which Key Players Are Driving Competition In The Infusion Therapy Devices Market?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, Acelity L.P Inc., LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., AccuVein Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

What Regional Growth Trends Are Shaping The Infusion Therapy Devices Market Outlook?

North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Infusion Therapy Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

Browse Through More Reports Similar to the Global Infusion Therapy Devices Market 2025, By The Business Research Company

Intravenous Infusion Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

Ambulatory Iv Infusion Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ambulatory-iv-infusion-pumps-global-market-report

Implantable Infusion Pumps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795